People channel feed – Endpoints News

People channel feed

STUNG: Aduro CEO Stephen Isaacs reaches for the budget ax — again — on the heels of their latest setback with Novartis

6 years ago

Credibility shredded, AMAG jettisons CEO and 2 drugs as it looks to reorganize around a salvage plan

6 years ago

Stanley and Rosanne Crooke stay focused on anti-sense, stealing back patients from disease with N-of-1 tech

6 years ago

'Burner' phones and Ariad secrets: Goldman Sachs banker pleads guilty for his role in global insider trading ring

6 years ago

Thomas Lynch finds a new home as leader of the Fred Hutch — and he’s staying focused on cancer breakthroughs

6 years ago

As investors soured on his bets, records show Woodford paid himself handsome dividends

6 years ago

'U snooze u lose': Judgment day for $100M biotech insider trading scheme looms as son of former Ariad director stands trial

6 years ago

As questions swirl around lead drug, FibroGen (and AstraZeneca) find a new champion from Big Pharma

6 years ago

‘No one expects to get a knighthood’: AstraZeneca’s Mene Pangalos knighted for his leading role in UK life sciences

6 years ago

Alkermes' head of early R&D jumps ship to newly created Harvard role

6 years ago

HHMI discriminated against two Asian American women investigators, lawsuits allege

6 years ago

David Meek hands in his CEO title at Ipsen, leaping across the Atlantic to run a startup prepping its first US drug launch

6 years ago

Bristol-Myers' strategy, BD chief Paul Biondi exited the company — just ahead of the $74B Celgene deal close

6 years ago

South Korea jails 3 Samsung execs for destroying evidence in BioLogics probe

6 years ago

One of Wall Street’s most high-profile hedge funds pushes Alexion's CEO to the auction block — and he's not budging

6 years ago

Sue Desmond-Hellmann says it's time for her to leave the Gates Foundation. Strategy chief Mark Suzman will now take the helm

6 years ago

As it shops for new deals, Akcea hires former GSK exec as COO

6 years ago

Biogen comes under renewed fire as a leading Alzheimer's expert raises serious questions about the aducanumab data

6 years ago

Senate committee backs Stephen Hahn as the next FDA commissioner

6 years ago

Agios taps Bristol-Myers vet Bruce Car to replace retiring CSO

6 years ago

Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co

6 years ago

Sanofi's strategy head to retire by month end, as company gears up for December strategic update

6 years ago

MorphoSys’ chief scientist hits the exit, triggering R&D reorganization as they shift focus to US in anticipation of looming FDA approval

6 years ago

Amgen chops 172 more staffers in R&D, operations and sales amid neuroscience exit, revenue downturn

6 years ago

First page Previous page 71 72 737475 76 77 Next page Last page